Dosage & Administration Drug label Prior authorization Financial assistance

Ofev

(nintedanib)

nintedanib 100 MG Oral Capsule [Ofev]nintedanib 150 MG Oral Capsule [Ofev]

NO BLACK BOX WARNING

Dosage & administration

* Recommended dosage: 150 mg taken orally twice daily approximately 12 hours apart taken with food.
* Recommended dosage in patients with mild hepatic impairment (Child Pugh A): 100 mg taken orally twice daily approximately 12 hours apart taken with food.
* Consider temporary dose reduction to 100 mg, treatment interruption, or discontinuation for management of adverse reactions.
* Prior to treatment initiation, conduct liver function tests in all patients and a pregnancy test in females of reproductive potential.

drug label

Ofev prescribing information

Need to report an Ofev issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Ofev Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDComplete Coverage Authorization appeals

Coverage Authorization Appeals - Physican: IPF

Coverage Authorization Appeals - Patient: IPF

Letter of Medical Necessity - Physician: IPF

Letter of Medical Necessity - Patient: IPF

PA Tips & Checklist: IPF

PA Tips & Checklist - Spanish: IPF

Appeals Tips & Checklist: IPF

Appeals Tips & Checklist - Spanish: IPF

Coverage Authorization Appeal - Physician: SSc-ILD

Coverage Authorization Appeals - Patient: SSc-ILD

Letter of Medical Exception: SSc-ILD

Letter of Medical Necessity: SSc-ILD

Coverage Authorization Appeals - Physician: Chronic Fibrosing ILDs with a Progressive Phenotype

Coverage Authorization Appeals - Patient: Chronic Fibrosing ILDs with a Progressive Phenotype

Letter of Medical Necessity: Chronic Fibrosing ILDs with a Progressive Phenotype

Letter of Medical Exception: Chronic Fibrosing ILDs with a Progressive Phenotype

Learn More

Benefits investigation

Ofev Prescription Form

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Ofev Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Bridge Program

Ofev Prescription Form

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

BI Cares Patient Assistance Program Application

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Ofev Patient education

Getting started on Ofev

NOT PROVIDED BY BRANDInstructions For Use: IPF

NOT PROVIDED BY BRANDInstructions For Use: Chronic Fibrosing ILDs with a Progressive Phenotype

NOT PROVIDED BY BRANDInstructions For Use: SSc-ILD